|
|
|
|
LEADER |
03564nam a2200697Ia 4500 |
001 |
10.2337-db21-0800 |
008 |
220706s2022 CNT 000 0 und d |
020 |
|
|
|a 1939327X (ISSN)
|
245 |
1 |
0 |
|a Mitofusins Mfn1 and Mfn2 Are Required to Preserve Glucose- but Not Incretin-Stimulated β-Cell Connectivity and Insulin Secretion
|
260 |
|
0 |
|b NLM (Medline)
|c 2022
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.2337/db21-0800
|
520 |
3 |
|
|a Mitochondrial glucose metabolism is essential for stimulated insulin release from pancreatic β-cells. Whether mitofusin gene expression, and hence, mitochondrial network integrity, is important for glucose or incretin signaling has not previously been explored. Here, we generated mice with β-cell-selective, adult-restricted deletion knock-out (dKO) of the mitofusin genes Mfn1 and Mfn2 (βMfn1/2 dKO). βMfn1/2-dKO mice displayed elevated fed and fasted glycemia and a more than fivefold decrease in plasma insulin. Mitochondrial length, glucose-induced polarization, ATP synthesis, and cytosolic and mitochondrial Ca2+ increases were all reduced in dKO islets. In contrast, oral glucose tolerance was more modestly affected in βMfn1/2-dKO mice, and glucagon-like peptide 1 or glucose-dependent insulinotropic peptide receptor agonists largely corrected defective glucose-stimulated insulin secretion through enhanced EPAC-dependent signaling. Correspondingly, cAMP increases in the cytosol, as measured with an Epac-camps-based sensor, were exaggerated in dKO mice. Mitochondrial fusion and fission cycles are thus essential in the β-cell to maintain normal glucose, but not incretin, sensing. These findings broaden our understanding of the roles of mitofusins in β-cells, the potential contributions of altered mitochondrial dynamics to diabetes development, and the impact of incretins on this process. © 2022 by the American Diabetes Association.
|
650 |
0 |
4 |
|a animal
|
650 |
0 |
4 |
|a Animals
|
650 |
0 |
4 |
|a genetics
|
650 |
0 |
4 |
|a glucose
|
650 |
0 |
4 |
|a Glucose
|
650 |
0 |
4 |
|a GTP Phosphohydrolases
|
650 |
0 |
4 |
|a guanine nucleotide exchange factor
|
650 |
0 |
4 |
|a Guanine Nucleotide Exchange Factors
|
650 |
0 |
4 |
|a guanosine triphosphatase
|
650 |
0 |
4 |
|a incretin
|
650 |
0 |
4 |
|a Incretins
|
650 |
0 |
4 |
|a insulin
|
650 |
0 |
4 |
|a Insulin
|
650 |
0 |
4 |
|a insulin release
|
650 |
0 |
4 |
|a Insulin Secretion
|
650 |
0 |
4 |
|a Insulin-Secreting Cells
|
650 |
0 |
4 |
|a knockout mouse
|
650 |
0 |
4 |
|a metabolism
|
650 |
0 |
4 |
|a Mfn1 protein, mouse
|
650 |
0 |
4 |
|a Mfn2 protein, mouse
|
650 |
0 |
4 |
|a Mice
|
650 |
0 |
4 |
|a Mice, Knockout
|
650 |
0 |
4 |
|a mouse
|
650 |
0 |
4 |
|a pancreas islet beta cell
|
700 |
1 |
|
|a Akalestou, E.
|e author
|
700 |
1 |
|
|a Ali, Y.
|e author
|
700 |
1 |
|
|a Alsabeeh, N.
|e author
|
700 |
1 |
|
|a Chabosseau, P.
|e author
|
700 |
1 |
|
|a Cruciani-Guglielmacci, C.
|e author
|
700 |
1 |
|
|a Georgiadou, E.
|e author
|
700 |
1 |
|
|a Gu, G.
|e author
|
700 |
1 |
|
|a Ibberson, M.
|e author
|
700 |
1 |
|
|a Jones, B.
|e author
|
700 |
1 |
|
|a Leclerc, I.
|e author
|
700 |
1 |
|
|a Legido-Quigley, C.
|e author
|
700 |
1 |
|
|a Linnemann, A.K.
|e author
|
700 |
1 |
|
|a Lopez-Noriega, L.
|e author
|
700 |
1 |
|
|a Magnan, C.
|e author
|
700 |
1 |
|
|a Martinez, M.
|e author
|
700 |
1 |
|
|a Muralidharan, C.
|e author
|
700 |
1 |
|
|a Rodriguez, T.A.
|e author
|
700 |
1 |
|
|a Rutter, G.A.
|e author
|
700 |
1 |
|
|a Soleimanpour, S.A.
|e author
|
700 |
1 |
|
|a Stylianides, T.
|e author
|
700 |
1 |
|
|a Tomas, A.
|e author
|
700 |
1 |
|
|a Wern, F.Y.S.
|e author
|
700 |
1 |
|
|a Wretlind, A.
|e author
|
700 |
1 |
|
|a Xu, Y.
|e author
|
773 |
|
|
|t Diabetes
|